What is Monopar Therapeutics Inc.'s stock symbol?

Our common stock is traded on the Nasdaq Capital Market under the ticker symbol “MNPR”. Our CUSIP number is 61023L 108.

When was Monopar Therapeutics Inc. incorporated?

We were incorporated in Delaware on December 16, 2015.

When did Monopar Therapeutics Inc. become a public company?

We became a public reporting company on January 8, 2018, and we began trading on Nasdaq on December 19, 2019.

Where is Monopar Therapeutics Inc. located?

Our headquarters is:

1000 Skokie Blvd.
Suite 350
Wilmette, IL 60091

When is Monopar Therapeutics Inc.'s fiscal year end?

December 31

Who is Monopar Therapeutics Inc.'s transfer agent?

The transfer agent and registrar for our common stock is VStock Transfer, LLC (VStock). VStock’s address is 18 Lafayette Place, Woodmere, NY 11598 and their email address is l-z@vstocktransfer.com. Please contact VStock if you are a stockholder and have questions about your direct investment in Monopar Therapeutics Inc.

Who is Monopar Therapeutics Inc.'s independent auditor?

Our independent auditors are BPM, LLP.

Who is Monopar Therapeutics Inc.'s outside legal counsel?

Our legal counsel is Baker Hostetler.